Cellulase/hyoscyamine/pancrelipase/phenyltoloxamine Interactions
There are 370 drugs known to interact with cellulase/hyoscyamine/pancrelipase/phenyltoloxamine, along with 24 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 10 are major, 342 are moderate, and 18 are minor.
- View all 370 medications that may interact with cellulase/hyoscyamine/pancrelipase/phenyltoloxamine
- View cellulase/hyoscyamine/pancrelipase/phenyltoloxamine alcohol/food interactions (2)
- View cellulase/hyoscyamine/pancrelipase/phenyltoloxamine disease interactions (24)
Most frequently checked interactions
View interaction reports for cellulase / hyoscyamine / pancrelipase / phenyltoloxamine and the medicines listed below.
- Creon (pancrelipase)
- Nicotinamide ZCF (multivitamin with minerals)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Quercetin (bioflavonoids)
- Redux (dexfenfluramine)
- Sotalol Hydrochloride AF (sotalol)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
Cellulase/hyoscyamine/pancrelipase/phenyltoloxamine alcohol/food interactions
There are 2 alcohol/food interactions with cellulase / hyoscyamine / pancrelipase / phenyltoloxamine.
Cellulase/hyoscyamine/pancrelipase/phenyltoloxamine disease interactions
There are 24 disease interactions with cellulase / hyoscyamine / pancrelipase / phenyltoloxamine which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- cardiac disease
- tachycardia
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- hyperuricemia
- hypertension
- hyperthyroidism
- diarrhea
- fever
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.